ACM
AURA icon

ADAR1 Capital Management’s Aura Biosciences AURA Stock Holding History

ADAR1 Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$924K Buy
+130,152
New +$931K 0.04% 177
2024
Q4 		– Sell
-73,663
Closed -$656K – 225
2024
Q3 		$656K Sell
73,663
-129,574
-64% -$1.11M 0.11% 101
2024
Q2 		$1.54M Buy
+203,237
New +$1.49M 0.29% 53

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ADAR1 Capital Management's AURA Position: Q2 2026 in Review

ADAR1 Capital Management opened a new position in Aura Biosciences (AURA) in Q2 2026: 130,152 shares worth $924K. The stake represents 0.04% of the portfolio and ranks #177 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in AURA as recently as Q3 2024.

ADAR1 Capital Management first reported a position in AURA in Q2 2024 and has held it in 3 quarters since. The position peaked at $1.54M in Q2 2024. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • ADAR1 Capital Management held 130,152 shares of Aura Biosciences worth $924K as of Q2 2026.
  • Aura Biosciences was a new ADAR1 Capital Management position in Q2 2026.
  • Aura Biosciences made up 0.04% of ADAR1 Capital Management's portfolio in Q2 2026, its #177 holding.
  • ADAR1 Capital Management first reported a position in Aura Biosciences in Q2 2024 and has held it in 3 quarters since.
  • ADAR1 Capital Management's Aura Biosciences position peaked at $1.54M in Q2 2024.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.